Literature DB >> 1267437

Minocycline resistance in Staphylococcus aureus: effect on phage susceptibility.

S Schaefler, W Francois, C L Ruby.   

Abstract

Tetracycline-resistant strains of Staphylococcus aureus are minocycline sensitive, with the exception of strains susceptible to phages of the 83A/84/85 complex and some methicillin-resistant strains of other phage types. Strains of the 83A/84/85 complex yield mutants with increased minocycline resistance. Transduction of minocycline resistance into the susceptible strain RN 450 was obtained with donor strains possessing either markers for both extrachromosomal tetracycline resistance (tet) and chromosomal tetracycline + minocycline resistance (tmn R), or only for chromosomal tmn R resistance. The chromosomal marker was differentiated from the extrachromosomal marker by the lack of detectable extrachromosomal deoxyribonucleic acid after transfer into strain RN 450, transfer into a rec(+) strain, lack of transfer into rec(-) acceptor strain, and cotransduction with chromosomal determinants for guanine biosynthesis. Both chromosomal and extrachromosomal tetracycline resistance can be induced by tetracycline. Induction by tetracycline of chromosomal tetracycline resistance resulted in simultaneous induction of minocycline resistance. The mutation toward increased minocycline resistance (tmn --> tmn R) is a regulatory mutation toward constitutivity or semiconstitutivity. Constitutive resistance is dominant in tmn R/tet diploids. Transfer of the tet marker does not affect the phage susceptibility of the acceptor strain. The tmn R marker, originating from donor strains of the 83A/84/85 complex, renders strain RN 450 resistant to several typing phages, with the exception of phages of the 83A/84/85 complex. This could possibly account for the phage typing patterns of minocycline-resistant staphylococci.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1267437      PMCID: PMC429585          DOI: 10.1128/AAC.9.4.600

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  The genetics of tetracycline resistance in Staphylococcus aureus.

Authors:  E H Asheshov
Journal:  J Gen Microbiol       Date:  1975-05

2.  Detection of an inducible membrane protein associated with R-factor-mediated tetracycline resistance.

Authors:  S B Levy; L McMurry
Journal:  Biochem Biophys Res Commun       Date:  1974-02-27       Impact factor: 3.575

3.  In vitro activity of minocycline, a new tetracycline.

Authors:  J Fedorko; S Katz; H Allnoch
Journal:  Am J Med Sci       Date:  1968-04       Impact factor: 2.378

4.  Genetic analysis of methicillin-resistant strains of Staphylococcus aureus; evidence for their evolution from a single clone.

Authors:  R W Lacey; J Grinsted
Journal:  J Med Microbiol       Date:  1973-11       Impact factor: 2.472

5.  Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an opern circular DNA form.

Authors:  D B Clewell; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

6.  Biochemical and genetic basis of tetracycline resistance in Staphylococcus aureus.

Authors:  I Chopra; R W Lacey; J Connolly
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

7.  Bacteriological evaluation of minocycline, a new tetracycline.

Authors:  J Klastersky; D Daneau
Journal:  Chemotherapy       Date:  1972       Impact factor: 2.544

8.  Transduction and elimination of resistance determinants in methicillin-resistant Staphylococcus aureus.

Authors:  F H Kayser; J Wüst; P Corrodi
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

9.  Resistance of Escherichia coli to tetracyclines. Changes in permeability to tetracyclines in Escherichia coli bearing transferable resistance factors.

Authors:  T J Franklin
Journal:  Biochem J       Date:  1967-10       Impact factor: 3.857

10.  Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci.

Authors:  J N Minuth; T M Holmes; D M Musher
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

View more
  9 in total

1.  Methicillin-resistant strains of Staphylococcus aureus phage type 92.

Authors:  S Schaefler; W Perry; D Jones
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

Review 2.  Antimicrobial resistance of Staphylococcus aureus: genetic basis.

Authors:  B R Lyon; R Skurray
Journal:  Microbiol Rev       Date:  1987-03

3.  Bacteriophage-mediated acquisition of antibiotic resistance by Staphylococcus aureus type 88.

Authors:  S Schaefler
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

4.  Bacterial resistance to the tetracyclines.

Authors:  I Chopra; T G Howe
Journal:  Microbiol Rev       Date:  1978-12

5.  Chromosomal mutations causing resistance to tetracycline in Bacillus subtilis.

Authors:  G Williams; I Smith
Journal:  Mol Gen Genet       Date:  1979

6.  Genetic linkage of chromosomal tetracycline resistance and pigmentation to a purine auxotrophic marker and the isoleucine-valine-leucine structural genes in Staphylococcus aureus.

Authors:  P A Pattee
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

7.  Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals.

Authors:  S Schaefler; D Jones; W Perry; L Ruvinskaya; T Baradet; E Mayr; M E Wilson
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

8.  Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

9.  Asymmetric Collagen/chitosan Membrane Containing Minocycline-loaded Chitosan Nanoparticles for Guided Bone Regeneration.

Authors:  Shiqing Ma; Aidina Adayi; Zihao Liu; Meng Li; Mingyao Wu; Linghao Xiao; Yingchun Sun; Qing Cai; Xiaoping Yang; Xu Zhang; Ping Gao
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.